Inhibition of an HIV-1 Tat-derived peptide binding to TAR RNA by aminoglycoside antibiotics
Authors:
- Houng-Yau MeiHMHoung-Yau Mei
- Adam A. GalanAGAdam A. Galan
- Nadia S. HalimNHNadia S. Halim
- David P. MackDMDavid P. Mack
- David W. MorelandDMDavid W. Moreland
- Kathryn B. SandersKSKathryn B. Sanders
- Hoa N. TruongHTHoa N. Truong
- Anthony W. CzarnikACAnthony W. Czarnik
- 1 November 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 5 (22) , 2755-2760
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Small molecules that selectively block RNA binding of HIV-1 rev protein inhibit rev function and viral productionCell, 1993
- Footprinting the Sites of Interaction of Antibiotics with Catalytic Group I Intron RNAScience, 1993
- Peptide models of the tat—Tar protein‐RNA interactionProtein Science, 1992
- Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibioticsJournal of Molecular Biology, 1992
- Arginine-Mediated RNA Recognition: the Arginine ForkScience, 1991
- Fragments of the HIV-1 Tat Protein Specifically Biand TAR RNAScience, 1990
- A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.Genes & Development, 1990
- Tat trans-activates the human immunodeficiency virus through a nascent RNA targetCell, 1989
- HIV-1 tat trans-activation requires the loop sequence within tarNature, 1988
- Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator proteinCell, 1987